Novasep Solutions for Biopharmaceutical Applications

Novasep Process biopharma business unit can help the life sciences industries that need to purify intermediates or bulk products derived from fermentation, blood/milk fractionation, plants or others with pharmaceutical application, when protection against microbial contamination during production is necessary.

Novasep Process Biopharma offers production downstream processing solutions to the biopharmaceutical industry for:

• Monoclonal Antibodies (mAbs)
• Recombinant Therapeutic Proteins (r-Proteins)
• Vaccines
• Peptides
• Polysaccharides

Benefits and Advantages

For monoclonal antibodies (mAbs), recombinant therapeutic proteins (r-Proteins), vaccines, peptides and polysaccharides, Novasep Process Biopharma offers solutions that:

Balance Downstream Productivity with Upstream Titres

With higher titres, with increasing competition, with ever more stringent quality and regulatory requirements, the challenge is to align the efficiency of downstream processing to upstream titres. Novasep Process Biopharma solutions offer unique features that help developing the optimum downstream processing to keep you up with your upstream.

Cut Cost while improving Productivity and Quality

The biopharmaceutical industry cannot compromise when it comes to quality and patient safety. Novasep Process Biopharma solutions comply with all regulatory and quality requirements with, for instance, on-line monitoring. These solutions allow cutting downstream processing cost down while increasing productivity and quality. Novasep Process Biopharma solutions ensure the highest quality and safety level while optimizing purity and yield.

Develop New Downstream Processing faster

The objectives of the biopharmaceutical industry are to bring new biomolecules faster to clinical stage, then faster into commercial products. Novasep cuts downstream processing development lead-time down using its modelling software. At a later stage, this modelling tool delivers rapid scale-ups with guaranteed results.